ROSEN A LEADING INVESTOR RIGHTS LAW FIRM Encourages Apellis Pharmaceuticals Inc Investors to Secure Counsel Before Important Deadline in Securities Class Action APLS The Lahore Times

New York, New York – Newsfile Corp. – August 22, 2023 – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) between January 28, 2021 and July 28, 2023, both dates inclusive (the “Class Period”), of the important…Read More

Leave a Reply

Your email address will not be published. Required fields are marked *